Health
Biogen Agrees to Pay $900 Million to Resolve Kickback Claims
This article is for subscribers only.
A Biogen Inc. whistle-blower will collect almost $250 million for bringing to light a kickback scheme the company agreed to resolve by paying the US and state governments $900 million.
The settlement resolves a lawsuit filed by former Biogen employee Michael Bawduniak under a whistle-blower provision of the False Claims Act, which permits individuals to sue on behalf of the US and get a cut of any money recovered, the government said in a statement on Monday.